BELZUTIFAN

BELZUTIFAN was reported 1777 times

BELZUTIFAN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 AORTIC ANEURYSM THROMBOSIS 1 0.5000
1 INFERIOR VENA CAVA COMPRESSION 1 0.1667
2 PHAKOMATOSIS 1 0.1429
3 RHABDOID TUMOUR OF THE KIDNEY 1 0.0909
4 HAEMANGIOBLASTOMA 4 0.0833
5 RENAL PELVIS FISTULA 1 0.0833
6 VASCULAR GRAFT OCCLUSION 27 0.0703
7 ANAEMIC HYPOXIA 1 0.0588
8 PERIPHERAL VASCULAR HAEMATOMA 1 0.0556
9 RESPIRATORY TRACT NEOPLASM 1 0.0417
10 BLOOD ERYTHROPOIETIN DECREASED 2 0.0345
11 CHRONIC CHEEK BITING 1 0.0233
12 PENETRATING AORTIC ULCER 1 0.0213
13 MAGNETIC RESONANCE IMAGING SPINAL ABNORMAL 2 0.0164
14 INTRACRANIAL TUMOUR HAEMORRHAGE 6 0.0155
15 CENTRAL NERVOUS SYSTEM INJURY 1 0.0154
16 LUNG NEOPLASM SURGERY 1 0.0152
17 DRUG THERAPY 5 0.0147
18 METASTASES TO DIAPHRAGM 1 0.0147
19 INTRACRANIAL MENINGIOMA MALIGNANT 1 0.0112
20 BENIGN NEOPLASM OF SPINAL CORD 1 0.0111
21 PANCREATIC DUCT STENOSIS 1 0.0110
22 AUTOIMMUNE MYOCARDITIS 2 0.0091
23 PROSTATIC MASS 1 0.0085
24 ANORECTAL INFECTION 2 0.0079
25 RENAL CELL CARCINOMA RECURRENT 1 0.0079
26 SPINAL CORD HAEMORRHAGE 3 0.0075
27 SPINAL CORD ISCHAEMIA 1 0.0066
28 LIVER SCAN ABNORMAL 1 0.0061
29 SPINAL CORD OEDEMA 2 0.0054
30 SPINAL CORD OPERATION 1 0.0052
31 CYSTITIS RADIATION 1 0.0052
32 HYDROCEPHALUS 28 0.0051
33 HYPERTENSIVE ENCEPHALOPATHY 3 0.0051
34 CORTISOL ABNORMAL 1 0.0050
35 HYPOXIA 174 0.0049
36 LYMPHANGIOSIS CARCINOMATOSA 5 0.0048
37 BACTERIAL DIARRHOEA 1 0.0047
38 SPINAL CORD HAEMATOMA 1 0.0047
39 RENAL NECROSIS 1 0.0046
40 MINERAL SUPPLEMENTATION 2 0.0045
41 KL-6 INCREASED 1 0.0044
42 CENTRAL NERVOUS SYSTEM HAEMORRHAGE 2 0.0043
43 RADIOTHERAPY 8 0.0042
44 JEJUNAL PERFORATION 1 0.0041
45 SCHIZOPHRENIFORM DISORDER 1 0.0041
46 SYRINGOMYELIA 1 0.0036
47 OMPHALITIS 1 0.0035
48 CANCER PAIN 9 0.0035
49 IMMUNE-MEDIATED HEPATITIS 7 0.0034
50 METASTASES TO HEART 1 0.0033
51 INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM 1 0.0033
52 GASTRIC HYPOMOTILITY 1 0.0033
53 INTRACRANIAL MASS 3 0.0032
54 TUMOUR COMPRESSION 1 0.0031
55 PAROTID GLAND ENLARGEMENT 2 0.0031
56 CEREBRAL CYST 2 0.0029
57 PELVIC NEOPLASM 1 0.0029
58 WOUND INFECTION 31 0.0028
59 DIALYSIS RELATED COMPLICATION 1 0.0028
60 CEREBELLAR HAEMORRHAGE 4 0.0028
61 IMMUNE-MEDIATED CHOLANGITIS 1 0.0028
62 INFECTED DERMAL CYST 1 0.0028
63 CEREBRAL MASS EFFECT 1 0.0028
64 FEEDING TUBE USER 1 0.0027
65 EAR OPERATION 1 0.0027
66 SCAN ABNORMAL 1 0.0027
67 IMMUNE-MEDIATED PANCREATITIS 1 0.0026
68 MALIGNANT ASCITES 2 0.0026
69 MALIGNANT NEOPLASM PROGRESSION 262 0.0026
70 HUMIDITY INTOLERANCE 1 0.0025
71 URETHRAL OBSTRUCTION 1 0.0025
72 CRANIOTOMY 1 0.0024
73 INFUSION 1 0.0024
74 FISTULA OF SMALL INTESTINE 1 0.0024
75 MALIGNANT PLEURAL EFFUSION 4 0.0024
76 NITRITE URINE PRESENT 1 0.0023
77 METASTASES TO PANCREAS 1 0.0023
78 VERTEBROPLASTY 1 0.0022
79 CARBON DIOXIDE INCREASED 3 0.0022
80 OXYGEN SATURATION ABNORMAL 6 0.0021
81 HYPERMETROPIA 2 0.0021
82 TYPE V HYPERLIPIDAEMIA 1 0.0021
83 DUODENAL STENOSIS 1 0.0021
84 CSF TEST ABNORMAL 1 0.0020
85 EXPOSURE VIA PARTNER 1 0.0020
86 OESOPHAGEAL ULCER HAEMORRHAGE 1 0.0020
87 RETINAL VASCULAR THROMBOSIS 1 0.0019
88 ASPARTATE AMINOTRANSFERASE DECREASED 1 0.0019
89 BLOOD GASES ABNORMAL 1 0.0019
90 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 3 0.0018
91 ANAEMIA 329 0.0017
92 XEROPHTHALMIA 1 0.0017
93 FEBRILE INFECTION 2 0.0017
94 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 2 0.0016
95 ARTHRITIS REACTIVE 1 0.0016
96 ACTIVITIES OF DAILY LIVING DECREASED 1 0.0016
97 BLOOD PRESSURE MEASUREMENT 1 0.0016
98 AUTOIMMUNE COLITIS 1 0.0016
99 MAGNETIC RESONANCE IMAGING HEAD ABNORMAL 1 0.0015
100 THERAPY PARTIAL RESPONDER 24 0.0015
101 IMMUNE-MEDIATED HEPATIC DISORDER 3 0.0015
102 HOSPICE CARE 15 0.0015
103 BLOOD POTASSIUM ABNORMAL 4 0.0015
104 CENTRAL SEROUS CHORIORETINOPATHY 1 0.0015
105 TUMOUR FLARE 1 0.0015
106 INGROWN HAIR 1 0.0014
107 CLEAR CELL RENAL CELL CARCINOMA 1 0.0014
108 PEPTIC ULCER HAEMORRHAGE 1 0.0014
109 PERIPHERAL MOTOR NEUROPATHY 2 0.0014
110 NOROVIRUS INFECTION 2 0.0014
111 ALANINE AMINOTRANSFERASE DECREASED 1 0.0014
112 NORMOCYTIC ANAEMIA 2 0.0014
113 BRAIN OPERATION 3 0.0013
114 ORAL SURGERY 3 0.0013
115 PNEUMONIA MYCOPLASMAL 1 0.0013
116 IMMUNE-MEDIATED ADRENAL INSUFFICIENCY 1 0.0013
117 THYROID HORMONES DECREASED 1 0.0013
118 VASCULAR ACCESS COMPLICATION 1 0.0012
119 MEDICAL PROCEDURE 2 0.0012
120 SEROUS RETINAL DETACHMENT 1 0.0012
121 VITAL FUNCTIONS ABNORMAL 1 0.0012
122 ACUTE SINUSITIS 2 0.0012
123 TREATMENT DELAYED 2 0.0012
124 ABDOMINAL LYMPHADENOPATHY 1 0.0012
125 THERAPY CHANGE 11 0.0011
126 IMMUNE-MEDIATED LUNG DISEASE 2 0.0011
127 OXYGEN SATURATION DECREASED 61 0.0011
128 ENTEROCOLITIS INFECTIOUS 1 0.0011
129 BUNDLE BRANCH BLOCK 1 0.0011
130 CYSTOID MACULAR OEDEMA 2 0.0011
131 BRAIN STEM HAEMORRHAGE 1 0.0011
132 RETINAL OEDEMA 2 0.0010
133 ONCOLOGIC COMPLICATION 1 0.0010
134 ADRENOCORTICAL INSUFFICIENCY ACUTE 2 0.0010
135 MASTOIDITIS 1 0.0010
136 RENAL MASS 2 0.0010
137 PROSTATIC SPECIFIC ANTIGEN ABNORMAL 1 0.0010
138 URETEROLITHIASIS 1 0.0010
139 RENAL NEOPLASM 2 0.0009
140 BLOOD SODIUM ABNORMAL 1 0.0009
141 AMAUROSIS FUGAX 1 0.0009
142 BINGE EATING 1 0.0009
143 HAEMORRHAGIC DISORDER 1 0.0009
144 TUMOUR LYSIS SYNDROME 8 0.0009
145 DANDRUFF 2 0.0009
146 CARDIAC FAILURE ACUTE 6 0.0009
147 CHRONIC GASTRITIS 2 0.0009
148 HYPERSENSITIVITY PNEUMONITIS 1 0.0009
149 HYPERTRANSAMINASAEMIA 6 0.0009
150 BILIRUBIN CONJUGATED INCREASED 2 0.0009
151 HYPOCHLORAEMIA 1 0.0009
152 MAGNETIC RESONANCE IMAGING ABNORMAL 1 0.0008
153 BILE DUCT STENOSIS 1 0.0008
154 HAEMATOMA MUSCLE 1 0.0008
155 BONE LESION 3 0.0008
156 VESTIBULAR DISORDER 1 0.0008
157 THERAPY INTERRUPTED 57 0.0008
158 PRODUCT USED FOR UNKNOWN INDICATION 1 0.0008
159 HAEMORRHAGE URINARY TRACT 2 0.0008
160 ENDOCRINE DISORDER 1 0.0008
161 HAEMOGLOBIN ABNORMAL 5 0.0008
162 BILIARY OBSTRUCTION 1 0.0008
163 ADRENAL INSUFFICIENCY 9 0.0007
164 NEUROENDOCRINE TUMOUR 1 0.0007
165 CHOLECYSTITIS ACUTE 4 0.0007
166 TUMOUR HAEMORRHAGE 2 0.0007
167 GENITAL RASH 1 0.0007
168 RETINAL VEIN OCCLUSION 2 0.0007
169 NONINFECTIVE GINGIVITIS 1 0.0007
170 DYSPNOEA AT REST 2 0.0007
171 PULMONARY SEPSIS 1 0.0007
172 PANCREATIC ENZYMES INCREASED 1 0.0007
173 RED BLOOD CELL COUNT ABNORMAL 1 0.0007
174 NEPHRECTOMY 1 0.0007
175 TRANSFUSION 7 0.0007
176 THYROIDITIS 2 0.0007
177 EYE ALLERGY 1 0.0006
178 HAEMOGLOBIN DECREASED 65 0.0006
179 INTERMITTENT CLAUDICATION 1 0.0006
180 PNEUMONITIS 17 0.0006
181 PORTAL VEIN THROMBOSIS 2 0.0006
182 PANCREATIC DISORDER 3 0.0006
183 BRADYARRHYTHMIA 1 0.0006
184 OXYGEN THERAPY 1 0.0006
185 SPLENIC INFARCTION 1 0.0006
186 PARAPARESIS 1 0.0006
187 ESSENTIAL HYPERTENSION 1 0.0005
188 LYMPH NODE PAIN 1 0.0005
189 LEUKOENCEPHALOPATHY 2 0.0005
190 SEDATION 14 0.0005
191 HYPOPROTEINAEMIA 1 0.0005
192 PROTEINURIA 10 0.0005
193 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 2 0.0005
194 MYOCARDITIS 6 0.0005
195 CLAVICLE FRACTURE 2 0.0005
196 ADRENAL DISORDER 1 0.0005
197 REHABILITATION THERAPY 2 0.0005
198 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 12 0.0005
199 ALCOHOL INTERACTION 1 0.0005
200 SPINAL CORD COMPRESSION 2 0.0005
201 PSYCHIATRIC DECOMPENSATION 1 0.0005
202 BICYTOPENIA 1 0.0005
203 COLOSTOMY 1 0.0005
204 CHOLECYSTITIS 6 0.0005
205 SUDDEN HEARING LOSS 1 0.0005
206 RENAL HAEMORRHAGE 1 0.0005
207 METASTASES TO BONE 8 0.0005
208 CHOLANGITIS 3 0.0005
209 SUBILEUS 1 0.0005
210 WALKING DISABILITY 1 0.0005
211 LUNG ABSCESS 1 0.0005
212 PERICARDIAL EFFUSION 11 0.0005
213 SLEEP DEFICIT 1 0.0005
214 FULL BLOOD COUNT ABNORMAL 5 0.0005
215 ENTERITIS 3 0.0005
216 RADIATION PNEUMONITIS 1 0.0005
217 METASTATIC NEOPLASM 2 0.0005
218 JAW FRACTURE 1 0.0005
219 BONE CANCER 2 0.0005
220 LYMPHOCYTE COUNT DECREASED 8 0.0005
221 BLOOD LOSS ANAEMIA 1 0.0004
222 CYTOMEGALOVIRUS COLITIS 1 0.0004
223 BLOOD THYROID STIMULATING HORMONE INCREASED 4 0.0004
224 NIGHTMARE 15 0.0004
225 NEPHROGENIC ANAEMIA 2 0.0004
226 PLEURAL EFFUSION 26 0.0004
227 VAGINAL INFECTION 2 0.0004
228 LACUNAR INFARCTION 1 0.0004
229 RENAL CELL CARCINOMA 2 0.0004
230 DENTAL OPERATION 1 0.0004
231 HEPATOTOXICITY 9 0.0004
232 INTRAVENTRICULAR HAEMORRHAGE 1 0.0004
233 GASTROINTESTINAL TUBE INSERTION 1 0.0004
234 FLUID INTAKE REDUCED 2 0.0004
235 DRUG TOLERANCE 2 0.0004
236 TOXIC ENCEPHALOPATHY 2 0.0004
237 PATHOLOGICAL FRACTURE 2 0.0004
238 LIPASE INCREASED 3 0.0004
239 ABDOMINAL INFECTION 1 0.0004
240 AORTIC ARTERIOSCLEROSIS 1 0.0004
241 PHYSICAL DECONDITIONING 1 0.0004
242 BLOOD CHLORIDE DECREASED 1 0.0004
243 TRISMUS 2 0.0004
244 CARDIAC FAILURE 31 0.0004
245 RED BLOOD CELL COUNT DECREASED 11 0.0004
246 HEPATITIS TOXIC 1 0.0004
247 BRAIN FOG 6 0.0004
248 RADICULOPATHY 1 0.0004
249 POLYARTHRITIS 2 0.0004
250 SCRATCH 4 0.0004
251 HEPATIC FUNCTION ABNORMAL 14 0.0004
252 ANAL FISTULA 2 0.0004
253 GASTROINTESTINAL INJURY 1 0.0004
254 SHOULDER ARTHROPLASTY 1 0.0004
255 ANAL ABSCESS 2 0.0004
256 ABDOMINAL RIGIDITY 1 0.0004
257 HICCUPS 3 0.0004
258 RASH MORBILLIFORM 1 0.0004
259 MACULE 1 0.0004
260 CHOLECYSTITIS INFECTIVE 1 0.0004
261 ALANINE AMINOTRANSFERASE INCREASED 22 0.0004
262 ASPARTATE AMINOTRANSFERASE INCREASED 19 0.0004
263 PROCTITIS 1 0.0004
264 MACULAR OEDEMA 2 0.0004
265 ENDOTRACHEAL INTUBATION 1 0.0004
266 DRUG TOLERANCE DECREASED 1 0.0004
267 BLOOD CALCIUM DECREASED 4 0.0004
268 PERIORBITAL SWELLING 2 0.0004
269 LUNG CANCER METASTATIC 1 0.0003
270 HYPONATRAEMIA 19 0.0003
271 HEPATITIS CHOLESTATIC 2 0.0003
272 HOSPITALISATION 51 0.0003
273 EMERGENCY CARE 1 0.0003
274 NEPHROLITHIASIS 15 0.0003
275 BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0003
276 PRODUCT DISTRIBUTION ISSUE 3 0.0003
277 HEPATIC ENCEPHALOPATHY 3 0.0003
278 IRIDOCYCLITIS 1 0.0003
279 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 3 0.0003
280 HYPOTHYROIDISM 10 0.0003
281 METASTASES TO CENTRAL NERVOUS SYSTEM 4 0.0003
282 DEAFNESS NEUROSENSORY 1 0.0003
283 INABILITY TO AFFORD MEDICATION 3 0.0003
284 NEPHRITIS 1 0.0003
285 POTENTIATING DRUG INTERACTION 1 0.0003
286 METASTASES TO LYMPH NODES 2 0.0003
287 SUDDEN CARDIAC DEATH 1 0.0003
288 THERAPY CESSATION 15 0.0003
289 NEPHROTIC SYNDROME 2 0.0003
290 RESPIRATION ABNORMAL 2 0.0003
291 ENCEPHALITIS 2 0.0003
292 HYPOPNOEA 1 0.0003
293 AUTOIMMUNE HEPATITIS 2 0.0003
294 AORTIC STENOSIS 1 0.0003
295 CAROTID ARTERY STENOSIS 1 0.0003
296 JAUNDICE CHOLESTATIC 1 0.0003
297 DIALYSIS 4 0.0003
298 RETINAL HAEMORRHAGE 2 0.0003
299 METASTASIS 2 0.0003
300 DISEASE PROGRESSION 33 0.0003
301 PRODUCT PRESCRIBING ISSUE 6 0.0003
302 PLATELET COUNT DECREASED 29 0.0003
303 IMMUNE-MEDIATED ENTEROCOLITIS 1 0.0003
304 AMYLASE INCREASED 1 0.0003
305 CARDIAC DYSFUNCTION 1 0.0003
306 HAEMORRHAGE INTRACRANIAL 4 0.0003
307 HEPATIC NECROSIS 1 0.0003
308 GINGIVAL DISORDER 1 0.0003
309 METASTASES TO LUNG 3 0.0003
310 BLOOD BILIRUBIN INCREASED 7 0.0003
311 OPTIC ISCHAEMIC NEUROPATHY 1 0.0003
312 TESTIS CANCER 1 0.0003
313 PROCEDURAL HAEMORRHAGE 1 0.0003
314 SUSPECTED COUNTERFEIT PRODUCT 1 0.0003
315 RENAL CYST 2 0.0003
316 BLOOD PRESSURE ABNORMAL 5 0.0003
317 HAEMOPTYSIS 7 0.0003
318 BLOOD DISORDER 2 0.0002
319 VITAMIN B12 DEFICIENCY 1 0.0002
320 TASTE DISORDER 5 0.0002
321 SHOCK HAEMORRHAGIC 2 0.0002
322 SPINAL OPERATION 3 0.0002
323 SELF-MEDICATION 1 0.0002
324 THYROID FUNCTION TEST ABNORMAL 1 0.0002
325 GASTROINTESTINAL PERFORATION 1 0.0002
326 BRAIN OEDEMA 3 0.0002
327 CARDIAC FAILURE CHRONIC 1 0.0002
328 SHOULDER OPERATION 1 0.0002
329 HEPATIC FAILURE 7 0.0002
330 HEPATIC LESION 1 0.0002
331 GROIN PAIN 2 0.0002
332 SPINAL OSTEOARTHRITIS 2 0.0002
333 ABDOMINAL ABSCESS 1 0.0002
334 GAMMA-GLUTAMYLTRANSFERASE INCREASED 5 0.0002
335 TRANSAMINASES INCREASED 5 0.0002
336 HAEMOLYTIC ANAEMIA 2 0.0002
337 IRON DEFICIENCY 1 0.0002
338 HAEMOGLOBIN INCREASED 1 0.0002
339 IMMUNE THROMBOCYTOPENIA 1 0.0002
340 CENTRAL NERVOUS SYSTEM LESION 3 0.0002
341 PNEUMONIA BACTERIAL 2 0.0002
342 BRAIN NEOPLASM 2 0.0002
343 ISCHAEMIA 1 0.0002
344 UROSEPSIS 2 0.0002
345 HYPOMAGNESAEMIA 3 0.0002
346 BLOOD CREATININE INCREASED 14 0.0002
347 PERFORMANCE STATUS DECREASED 1 0.0002
348 BLOOD TEST ABNORMAL 3 0.0002
349 TIBIA FRACTURE 1 0.0002
350 SINUS TACHYCARDIA 3 0.0002
351 COLITIS MICROSCOPIC 1 0.0002
352 CARDIAC TAMPONADE 1 0.0002
353 PARALYSIS 3 0.0002
354 LIMB OPERATION 1 0.0002
355 DIZZINESS POSTURAL 2 0.0002
356 THROMBOTIC MICROANGIOPATHY 2 0.0002
357 HAEMORRHOIDAL HAEMORRHAGE 1 0.0002
358 SURGERY 12 0.0002
359 HAEMATURIA 7 0.0002
360 SKIN HAEMORRHAGE 3 0.0002
361 HYPERVOLAEMIA 1 0.0002
362 FOOT OPERATION 1 0.0002
363 HAEMATOCRIT DECREASED 4 0.0002
364 DRUG INTERACTION 32 0.0002
365 ADVERSE DRUG REACTION 18 0.0002
366 FULL BLOOD COUNT DECREASED 4 0.0002
367 TOXIC EPIDERMAL NECROLYSIS 3 0.0002
368 NEUTROPHIL COUNT DECREASED 8 0.0002
369 CACHEXIA 1 0.0002
370 HYPERBILIRUBINAEMIA 2 0.0002
371 C-REACTIVE PROTEIN INCREASED 7 0.0002
372 WEIGHT FLUCTUATION 2 0.0002
373 CATATONIA 1 0.0002
374 GINGIVITIS 1 0.0002
375 DECREASED ACTIVITY 2 0.0002
376 BLOOD POTASSIUM INCREASED 3 0.0002
377 COLITIS 7 0.0002
378 NONSPECIFIC REACTION 1 0.0002
379 HYPERKERATOSIS 1 0.0002
380 GASTRIC ULCER HAEMORRHAGE 1 0.0002
381 RASH MACULO-PAPULAR 4 0.0002
382 MALNUTRITION 2 0.0002
383 SKIN INFECTION 2 0.0002
384 FISTULA 2 0.0002
385 SCAB 2 0.0002
386 NEUROLOGICAL SYMPTOM 1 0.0002
387 ADVERSE EVENT 16 0.0002
388 ENTEROCOLITIS 1 0.0002
389 BLOOD URIC ACID INCREASED 1 0.0002
390 HYPERVENTILATION 1 0.0002
391 METABOLIC DISORDER 1 0.0002
392 ELECTROLYTE IMBALANCE 2 0.0002
393 RENAL DISORDER 8 0.0002
394 HYPERKALAEMIA 6 0.0002
395 HYPERTRIGLYCERIDAEMIA 1 0.0002
396 ACUTE MYOCARDIAL INFARCTION 5 0.0002
397 DRUG ERUPTION 3 0.0002
398 CEREBRAL HAEMORRHAGE 6 0.0002
399 FATIGUE 129 0.0002
400 NO ADVERSE EVENT 30 0.0002
401 FOETAL GROWTH RESTRICTION 1 0.0002
402 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0002
403 MENISCUS INJURY 1 0.0002
404 HYPERCALCAEMIA 2 0.0002
405 PIGMENTATION DISORDER 1 0.0002
406 GENERALISED OEDEMA 2 0.0002
407 FEMUR FRACTURE 5 0.0002
408 OLIGURIA 1 0.0002
409 AGEUSIA 4 0.0002
410 DRUG-INDUCED LIVER INJURY 5 0.0002
411 LIVER DISORDER 7 0.0002
412 HEPATIC CYTOLYSIS 2 0.0002
413 ACUTE RESPIRATORY FAILURE 3 0.0002
414 GALACTORRHOEA 1 0.0002
415 INCOHERENT 1 0.0002
416 REFUSAL OF TREATMENT BY PATIENT 1 0.0002
417 BRADYPHRENIA 1 0.0002
418 HYPOKALAEMIA 7 0.0002
419 ADVERSE REACTION 2 0.0002
420 TERMINAL STATE 1 0.0001
421 BRONCHIECTASIS 1 0.0001
422 ULCER HAEMORRHAGE 1 0.0001
423 UVEITIS 2 0.0001
424 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 1 0.0001
425 RENAL CANCER 7 0.0001
426 HEPATIC ENZYME INCREASED 10 0.0001
427 MATERNAL EXPOSURE BEFORE PREGNANCY 1 0.0001
428 ACUTE HEPATIC FAILURE 2 0.0001
429 LYMPHOEDEMA 1 0.0001
430 DEFAECATION URGENCY 1 0.0001
431 PULMONARY TOXICITY 1 0.0001
432 LYMPHADENOPATHY 5 0.0001
433 PANIC REACTION 1 0.0001
434 COMPLICATION ASSOCIATED WITH DEVICE 2 0.0001
435 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
436 SENSITIVE SKIN 1 0.0001
437 LABORATORY TEST ABNORMAL 4 0.0001
438 CEREBRAL DISORDER 1 0.0001
439 DRUG EFFECT LESS THAN EXPECTED 2 0.0001
440 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 1 0.0001
441 HYPOAESTHESIA ORAL 2 0.0001
442 PANCREATITIS 7 0.0001
443 HYPERTENSION 28 0.0001
444 CORONARY ARTERY DISEASE 4 0.0001
445 AORTIC ANEURYSM 1 0.0001
446 EPILEPSY 4 0.0001
447 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 1 0.0001
448 EJECTION FRACTION DECREASED 2 0.0001
449 PNEUMONIA 41 0.0001
450 GINGIVAL PAIN 1 0.0001
451 INTERSTITIAL LUNG DISEASE 6 0.0001
452 FRUSTRATION TOLERANCE DECREASED 1 0.0001
453 DYSPNOEA 70 0.0001
454 DECUBITUS ULCER 1 0.0001
455 PRODUCT DOSE OMISSION ISSUE 36 0.0001
456 LIVER INJURY 3 0.0001
457 ENCEPHALOPATHY 3 0.0001
458 HAIR DISORDER 1 0.0001
459 BLOOD ALKALINE PHOSPHATASE INCREASED 3 0.0001
460 ACUTE CORONARY SYNDROME 1 0.0001
461 EMBOLISM 1 0.0001
462 CARDIOVASCULAR DISORDER 3 0.0001
463 FACIAL PARALYSIS 1 0.0001
464 FALL 39 0.0001
465 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2 0.0001
466 NAIL DISORDER 1 0.0001
467 LUNG INFILTRATION 1 0.0001
468 RESPIRATORY RATE INCREASED 1 0.0001
469 DECREASED APPETITE 26 0.0001
470 THIRST 2 0.0001
471 JAUNDICE 3 0.0001
472 MYOSITIS 1 0.0001
473 HEAVY MENSTRUAL BLEEDING 1 0.0001
474 ACUTE KIDNEY INJURY 17 0.0001
475 SKIN LESION 3 0.0001
476 INCREASED TENDENCY TO BRUISE 1 0.0001
477 HYPERHIDROSIS 14 0.0001
478 IRON DEFICIENCY ANAEMIA 1 0.0001
479 BLOOD GLUCOSE ABNORMAL 2 0.0001
480 PRODUCT USE ISSUE 20 0.0001
481 DYSPNOEA EXERTIONAL 4 0.0001
482 PRODUCT DOSE OMISSION IN ERROR 3 0.0001
483 PAIN IN JAW 3 0.0001
484 SPUTUM DISCOLOURED 1 0.0001
485 BLOOD URINE PRESENT 2 0.0001
486 BLOOD PRESSURE DECREASED 7 0.0001
487 HAEMATOTOXICITY 1 0.0001
488 PULMONARY EMBOLISM 10 0.0001
489 INTENTIONAL DOSE OMISSION 3 0.0001
490 INCREASED APPETITE 2 0.0001
491 LETHARGY 6 0.0001
492 CHOLESTASIS 2 0.0001
493 ATELECTASIS 1 0.0001
494 AUTOIMMUNE DISORDER 1 0.0001
495 HAEMORRHOIDS 2 0.0001
496 DIARRHOEA 66 0.0001
497 LIGAMENT SPRAIN 1 0.0001
498 UPPER LIMB FRACTURE 2 0.0001
499 FEEDING DISORDER 2 0.0001
500 FLUID RETENTION 5 0.0001
501 SUBARACHNOID HAEMORRHAGE 1 0.0001
502 EAR DISCOMFORT 1 0.0001
503 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 1 0.0001
504 TEMPERATURE INTOLERANCE 1 0.0001
505 PRODUCT USE IN UNAPPROVED INDICATION 24 0.0001
506 VENTRICULAR EXTRASYSTOLES 1 0.0001
507 RESPIRATORY FAILURE 7 0.0001
508 ASTHENIA 36 0.0001
509 UNINTENDED PREGNANCY 1 0.0001
510 RENAL IMPAIRMENT 8 0.0001
511 JOINT DISLOCATION 1 0.0001
512 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
513 LIVER FUNCTION TEST INCREASED 2 0.0001
514 DEATH 80 0.0001
515 BALANCE DISORDER 8 0.0001
516 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
517 OEDEMA 5 0.0001
518 DEVICE DISLOCATION 4 0.0001
519 COVID-19 16 0.0001
520 GLOSSODYNIA 2 0.0001
521 PULMONARY OEDEMA 4 0.0001
522 ORAL PAIN 2 0.0001
523 INTESTINAL PERFORATION 1 0.0001
524 THERAPY NON-RESPONDER 4 0.0001
525 PANCREATITIS ACUTE 2 0.0001
526 TRANSIENT ISCHAEMIC ATTACK 3 0.0001
527 URINARY TRACT INFECTION 15 0.0001
528 MYOCARDIAL ISCHAEMIA 1 0.0001
529 INTERNAL HAEMORRHAGE 1 0.0001
530 ILLNESS 9 0.0001
531 TINNITUS 4 0.0001
532 SHOCK 2 0.0001
533 NEOPLASM PROGRESSION 3 0.0001
534 EYELID OEDEMA 1 0.0001
535 DYSPHONIA 5 0.0001
536 SPINAL PAIN 1 0.0001
537 COVID-19 PNEUMONIA 1 0.0001
538 BLOOD IRON DECREASED 1 0.0001
539 WRIST FRACTURE 1 0.0001
540 LOCALISED INFECTION 2 0.0001
541 DEHYDRATION 11 0.0001
542 DRY SKIN 11 0.0001
543 ILL-DEFINED DISORDER 5 0.0001
544 NEURALGIA 2 0.0001
545 MALAISE 36 0.0001
546 CEREBRAL INFARCTION 2 0.0001
547 CYTOPENIA 1 0.0001
548 RESPIRATORY DEPRESSION 1 0.0001
549 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
550 CARDIOMEGALY 1 0.0001
551 TENDON RUPTURE 1 0.0001
552 SEPSIS 9 0.0001
553 PHARYNGITIS 1 0.0001
554 THROMBOCYTOPENIA 9 0.0001
555 ILEUS 1 0.0001
556 CONFUSIONAL STATE 13 0.0001
557 EPISTAXIS 6 0.0001
558 GASTRIC CANCER 2 0.0001
559 HYPOPHAGIA 2 0.0001
560 HEPATITIS 2 0.0001
561 CONSTIPATION 17 0.0001
562 PERIPHERAL SWELLING 12 0.0001
563 ROTATOR CUFF SYNDROME 1 0.0001
564 HAEMORRHAGE 8 0.0001
565 SARS-COV-2 TEST POSITIVE 1 0.0001
566 CARDIAC FAILURE CONGESTIVE 6 0.0001
567 THROMBOSIS 6 0.0001
568 NAUSEA 59 0.0001
569 INCORRECT DOSE ADMINISTERED 17 0.0001
570 OFF LABEL USE 65 0.0001
571 BLINDNESS 3 0.0001
572 PERIPHERAL COLDNESS 1 0.0001
573 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 13 0.0001
574 DEMENTIA 2 0.0001
575 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
576 DIZZINESS 35 0.0001
577 BRONCHOSPASM 1 0.0001
578 SYNCOPE 7 0.0001
579 SUBDURAL HAEMATOMA 1 0.0001
580 RECTAL HAEMORRHAGE 3 0.0001
581 ANGINA PECTORIS 2 0.0001
582 CARDIOGENIC SHOCK 1 0.0001
583 HYPERTHYROIDISM 1 0.0001
584 PULMONARY ARTERIAL HYPERTENSION 1 0.0001
585 HYPOKINESIA 1 0.0001
586 ABDOMINAL PAIN 16 0.0001
587 LIVER FUNCTION TEST ABNORMAL 2 0.0001
588 GASTROENTERITIS 1 0.0001
589 CARDIOMYOPATHY 1 0.0001
590 PULMONARY MASS 1 0.0001
591 BLOOD POTASSIUM DECREASED 2 0.0001
592 PYREXIA 23 0.0001
593 OEDEMA PERIPHERAL 8 0.0001
594 LYMPHOMA 1 0.0001
595 TENDONITIS 1 0.0001
596 WHITE BLOOD CELL COUNT DECREASED 7 0.0001
597 VISUAL IMPAIRMENT 8 0.0001
598 ACUTE MYELOID LEUKAEMIA 1 0.0001
599 PRODUCT USE COMPLAINT 1 0.0001
600 ARRHYTHMIA 3 0.0001
601 HEAD INJURY 2 0.0001
602 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
603 PNEUMOTHORAX 1 0.0001
604 MYOCARDIAL INFARCTION 11 0.0001
605 HALLUCINATION, AUDITORY 1 0.0001
606 ARTHRALGIA 26 0.0001
607 OSTEONECROSIS 2 0.0001
608 VISUAL ACUITY REDUCED 2 0.0001
609 HYPOAESTHESIA 9 0.0001
610 DRY EYE 3 0.0001
611 URINARY RETENTION 2 0.0001
612 GAIT INABILITY 2 0.0001
613 PERICARDITIS 1 0.0001
614 UPPER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
615 FACE OEDEMA 1 0.0001
616 HEMIPARESIS 1 0.0001
617 MYALGIA 10 0.0001
618 ORTHOSTATIC HYPOTENSION 1 0.0001
619 EOSINOPHILIA 1 0.0001
620 HEART RATE DECREASED 2 0.0001
621 METASTASES TO LIVER 1 0.0001
622 HEAD DISCOMFORT 1 0.0001
623 GOUT 1 0.0001
624 MYELOSUPPRESSION 2 0.0001
625 VOMITING 26 0.0001
626 INFECTION 8 0.0001
627 BONE DISORDER 1 0.0001
628 CONJUNCTIVITIS 1 0.0001
629 BLISTER 3 0.0001
630 BLOOD SODIUM DECREASED 1 0.0001
631 FRACTURE 1 0.0001
632 MUSCULOSKELETAL DISORDER 1 0.0001
633 DIABETES MELLITUS 4 0.0001
634 BLOOD PRESSURE INCREASED 8 0.0001
635 GENERAL PHYSICAL HEALTH DETERIORATION 6 0.0001
636 DRUG INTOLERANCE 5 0.0001
637 HERNIA 1 0.0001
638 ATRIAL FIBRILLATION 5 0.0001
639 NASAL CONGESTION 3 0.0001
640 VISION BLURRED 7 0.0001
641 SINUS DISORDER 1 0.0001
642 SPINAL FRACTURE 1 0.0000
643 HYPOTENSION 10 0.0000
644 STOMATITIS 3 0.0000
645 HEADACHE 31 0.0000
646 EXTRA DOSE ADMINISTERED 2 0.0000
647 RIB FRACTURE 1 0.0000
648 ABDOMINAL PAIN UPPER 10 0.0000
649 GASTROINTESTINAL HAEMORRHAGE 4 0.0000
650 CARDIO-RESPIRATORY ARREST 2 0.0000
651 BACK PAIN 11 0.0000
652 OSTEOARTHRITIS 2 0.0000
653 JOINT INJURY 1 0.0000
654 FAECES DISCOLOURED 1 0.0000
655 AMNESIA 3 0.0000
656 VAGINAL HAEMORRHAGE 2 0.0000
657 PRODUCT DISPENSING ERROR 1 0.0000
658 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
659 MELAENA 1 0.0000
660 STEVENS-JOHNSON SYNDROME 1 0.0000
661 TOOTH DISORDER 1 0.0000
662 MATERNAL EXPOSURE DURING PREGNANCY 4 0.0000
663 SOMNOLENCE 9 0.0000
664 GASTROINTESTINAL DISORDER 4 0.0000
665 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
666 LOWER RESPIRATORY TRACT INFECTION 2 0.0000
667 SEIZURE 5 0.0000
668 SWELLING 4 0.0000
669 PALPITATIONS 5 0.0000
670 SLEEP DISORDER 3 0.0000
671 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3 0.0000
672 COMA 2 0.0000
673 MOBILITY DECREASED 3 0.0000
674 BLOOD GLUCOSE DECREASED 2 0.0000
675 MENTAL IMPAIRMENT 1 0.0000
676 LUNG DISORDER 2 0.0000
677 PNEUMONIA ASPIRATION 1 0.0000
678 HALLUCINATION 3 0.0000
679 UNEVALUABLE EVENT 3 0.0000
680 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
681 DRUG INEFFECTIVE 52 0.0000
682 LOSS OF CONSCIOUSNESS 5 0.0000
683 DRUG RESISTANCE 1 0.0000
684 INFLAMMATION 2 0.0000
685 UNRESPONSIVE TO STIMULI 1 0.0000
686 SKIN ULCER 1 0.0000
687 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
688 ABDOMINAL DISTENSION 4 0.0000
689 DEAFNESS 1 0.0000
690 JOINT STIFFNESS 1 0.0000
691 GASTRITIS 1 0.0000
692 RENAL FAILURE 5 0.0000
693 PAIN 23 0.0000
694 GASTROOESOPHAGEAL REFLUX DISEASE 3 0.0000
695 BLOOD GLUCOSE INCREASED 7 0.0000
696 DISTURBANCE IN ATTENTION 2 0.0000
697 FREQUENT BOWEL MOVEMENTS 1 0.0000
698 THROAT TIGHTNESS 1 0.0000
699 PALLOR 1 0.0000
700 TREATMENT NONCOMPLIANCE 2 0.0000
701 PRURITUS 14 0.0000
702 MEMORY IMPAIRMENT 5 0.0000
703 RESPIRATORY DISTRESS 1 0.0000
704 ANAPHYLACTIC REACTION 2 0.0000
705 PROCEDURAL PAIN 1 0.0000
706 FEELING COLD 1 0.0000
707 PANCYTOPENIA 2 0.0000
708 WOUND 1 0.0000
709 SKIN EXFOLIATION 3 0.0000
710 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
711 MUSCULAR WEAKNESS 4 0.0000
712 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
713 HYPERSOMNIA 1 0.0000
714 DYSSTASIA 1 0.0000
715 BONE PAIN 2 0.0000
716 ASCITES 1 0.0000
717 RENAL INJURY 1 0.0000
718 APHASIA 1 0.0000
719 LACRIMATION INCREASED 1 0.0000
720 VERTIGO 2 0.0000
721 DISCOMFORT 2 0.0000
722 EMOTIONAL DISORDER 1 0.0000
723 OROPHARYNGEAL PAIN 3 0.0000
724 LIMB DISCOMFORT 1 0.0000
725 WEIGHT DECREASED 9 0.0000
726 EXPOSURE DURING PREGNANCY 2 0.0000
727 RASH 14 0.0000
728 SWOLLEN TONGUE 1 0.0000
729 DYSPHAGIA 3 0.0000
730 CYSTITIS 1 0.0000
731 GAIT DISTURBANCE 6 0.0000
732 METABOLIC ACIDOSIS 1 0.0000
733 CONTUSION 3 0.0000
734 HIP FRACTURE 1 0.0000
735 NIGHT SWEATS 1 0.0000
736 DEEP VEIN THROMBOSIS 2 0.0000
737 SWELLING FACE 2 0.0000
738 IMPAIRED HEALING 1 0.0000
739 EYE DISORDER 1 0.0000
740 HEART RATE INCREASED 3 0.0000
741 NEOPLASM MALIGNANT 2 0.0000
742 CEREBROVASCULAR ACCIDENT 5 0.0000
743 DELIRIUM 1 0.0000
744 RASH MACULAR 1 0.0000
745 COUGH 8 0.0000
746 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
747 HYPERGLYCAEMIA 1 0.0000
748 ACCIDENTAL OVERDOSE 1 0.0000
749 DYSARTHRIA 1 0.0000
750 INTESTINAL OBSTRUCTION 1 0.0000
751 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
752 DISORIENTATION 1 0.0000
753 FEELING ABNORMAL 6 0.0000
754 ABORTION SPONTANEOUS 1 0.0000
755 JOINT SWELLING 3 0.0000
756 DRY MOUTH 2 0.0000
757 CARDIAC ARREST 2 0.0000
758 RHABDOMYOLYSIS 1 0.0000
759 ROAD TRAFFIC ACCIDENT 1 0.0000
760 SEPTIC SHOCK 1 0.0000
761 WEIGHT INCREASED 5 0.0000
762 NEUTROPENIA 3 0.0000
763 SUICIDAL IDEATION 2 0.0000
764 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
765 BLOOD CHOLESTEROL INCREASED 1 0.0000
766 COGNITIVE DISORDER 1 0.0000
767 PRODUCTIVE COUGH 1 0.0000
768 RASH ERYTHEMATOUS 1 0.0000
769 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
770 HYPOGLYCAEMIA 1 0.0000
771 ALOPECIA 4 0.0000
772 PAIN IN EXTREMITY 6 0.0000
773 LEUKOPENIA 1 0.0000
774 CELLULITIS 1 0.0000
775 SINUSITIS 2 0.0000
776 SPEECH DISORDER 1 0.0000
777 DEPRESSED MOOD 1 0.0000
778 BRADYCARDIA 1 0.0000
779 RASH PRURITIC 1 0.0000
780 EYE PAIN 1 0.0000
781 FLATULENCE 1 0.0000
782 PRODUCT SUBSTITUTION ISSUE 1 0.0000
783 CHILLS 2 0.0000
784 WHEEZING 1 0.0000
785 CATARACT 1 0.0000
786 SUICIDE ATTEMPT 1 0.0000
787 CONDITION AGGRAVATED 5 0.0000
788 NASOPHARYNGITIS 3 0.0000
789 RHINORRHOEA 1 0.0000
790 FEBRILE NEUTROPENIA 1 0.0000
791 INJURY 1 0.0000
792 UNDERDOSE 1 0.0000
793 AGITATION 1 0.0000
794 BRONCHITIS 1 0.0000
795 DYSGEUSIA 1 0.0000
796 CHRONIC KIDNEY DISEASE 1 0.0000
797 ARTHRITIS 1 0.0000
798 INJECTION SITE HAEMORRHAGE 1 0.0000
799 PROSTATE CANCER 1 0.0000
800 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
801 TREMOR 2 0.0000
802 TOXICITY TO VARIOUS AGENTS 2 0.0000
803 MUSCULOSKELETAL STIFFNESS 1 0.0000
804 INSOMNIA 3 0.0000
805 MUSCLE SPASMS 2 0.0000
806 CHEST PAIN 2 0.0000
807 CARDIAC DISORDER 1 0.0000
808 NEUROPATHY PERIPHERAL 1 0.0000
809 MIGRAINE 1 0.0000
810 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
811 DEPRESSION 2 0.0000
812 URTICARIA 1 0.0000
813 ABDOMINAL DISCOMFORT 1 0.0000
814 HYPERSENSITIVITY 1 0.0000
815 ERYTHEMA 1 0.0000
816 OVERDOSE 1 0.0000
817 ANXIETY 1 0.0000